AutoICD API

101583-3

Laboratory

ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Interpretation] by based on lab data in Positive blood culture Qualitative

LOINC 6-Axis Classification

Component

Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio

Property

Imp

Time Aspect

Pt

System

Bld.pos growth

Scale Type

Ord

Method Type

Based on lab data

Details

Class

ABXBACT

Order/Observation

Both

Short Name

ESBL cft to cft-clav IC rto Bd Pos Imp

Display Name

ESBL by ceftazidime to ceftazidime-clavulanate IC ratio based on lab data Ql (Pos bld culture) [Interp]

Related Names

ANTIBIOTIC SUSCEPTIBILITIESBBetalactamaseB-LactamaseBld PosBloodc305CeftazClavClavateClavuClavulClavulanicClavulanic acidESBL by ceftaz to ceft-clav IC rtoForjFortazfrom lab dataImpressionImpression/interpretation of studyImpressionsInterpInterpretationOrdinalPoint in timeQLQualQualitativeRandomScreenTazicefTazjWBWhole blood

Frequently Asked Questions

What is LOINC code 101583-3?

LOINC code 101583-3 identifies "ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Interpretation] by based on lab data in Positive blood culture Qualitative". It measures Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio in Bld.pos growth.

What does 101583-3 measure?

This code measures Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio in Bld.pos growth. It belongs to the ABXBACT class in the LOINC classification.

What is LOINC?

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.